Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death (Q45394626)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death |
scientific article published in July 2008 |
Statements
1 reference
Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death (English)
1 reference
Cecilia T Costiniuk
1 reference
Fernando Camacho
1 reference
Curtis L Cooper
1 reference
1 July 2008
1 reference
1 reference
47
1 reference
2
1 reference
198-202
1 reference
Identifiers
1 reference
1 reference